Clinical Trials Logo
  1. Home
  2. Rectal Cancer
  3. NCT06006260
  4. Details
NCT06006260 Clinical Trial

Changes of Low Anterior Resection Syndrome and Balance Ability in Patients With Rectal Cancer.

Rectal Cancer Clinical Trial

Official title:
Changes of Low Anterior Resection Syndrome, Balance Ability, and Quality of Life in Patients With Newly Diagnosed Rectal Cancer.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06006260
Other study ID # 20220197B0
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 20, 2023
Est. completion date August 31, 2024

Study information
Verified date February 2024
Source Chang Gung Memorial Hospital
Contact Yun-Jen Chou, PhD
Phone +886-3-2118800
Email yjchou@mail.cgu.edu.tw
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purposes of this study are to explore the trajectory of symptom distress and balance ability in patients with rectal cancer.

Recruitment information / eligibility
Status Recruiting
Enrollment 110
Est. completion date August 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: 1. Newly diagnosed rectal cancer 2. Patients already know their condition. 3. Aged 20 years and older. 4. Consciously communicate in Mandarin or Taiwanese. 5. Agreed with the interview and had signed the permit. Exclusion Criteria: 1. Recurrent rectal cancer. 2. KPS of patients less than 80

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Taiwan Chung Gung University Taoyuan City Kwei-Shan Dist.

Sponsors (1)
Lead Sponsor Collaborator
Chang Gung Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Self-report Questionnaire Show the specific trajectory of LAR Syndrome, psychological distress, fecal incontinence-related QoL, and balance ability based on different tumor locations in patients with rectal cancer Change from baseline symptom at 2 months
See also
  Status Clinical Trial Phase
Recruiting NCT06380101 - Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) N/A
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT04323722 - Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Active, not recruiting NCT01347697 - Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer N/A
Recruiting NCT04495088 - Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer Phase 3
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Not yet recruiting NCT03520088 - PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS N/A
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT04749381 - The Role of TCM on ERAS of Rectal Cancer Patients Phase 2
Enrolling by invitation NCT05028192 - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Recruiting NCT03283540 - Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Completed NCT04534309 - Behavioral Weight Loss Program for Cancer Survivors in Maryland N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Recruiting NCT04852653 - A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Terminated NCT02933944 - Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer Phase 1